Skip to main content

Advertisement

SpringerLink
Log in

HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

HIV-associated neurocognitive disorders (HAND) are the most common preventable and treatable cause of dementia. While the incidence of the most severe form of HAND, HIV-associated dementia, has decreased since the introduction of combination antiretroviral therapy (cART), the prevalence of less severe forms of HAND has continued to rise. HAND leads to a subcortical dementia consisting of a triad of cognitive, behavior, and motor dysfunction. No single laboratory test can establish HAND, but ancillary studies including neuropsychological testing, neuroimaging studies, and cerebrospinal fluid (CSF) analysis are useful for supporting or refuting the diagnosis. More recent evidence has suggested that higher central nervous system-penetrating cART may lead to greater suppression of CSF HIV viral loads and improved cognition. Because viral control generally has been successful without eliminating cognitive dysfunction, further clinical studies that assess adjunctive neuroprotective drugs are likely to be required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gartner S, Markovits P, Markovitz DM, et al.: Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 1986, 256:2365–2371.

    Article  PubMed  CAS  Google Scholar 

  2. Navia BA, Cho ES, Petito CK, Price RW: The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986, 19:525–535.

    Article  PubMed  CAS  Google Scholar 

  3. Navia BA, Jordan BD, Price RW: The AIDS dementia complex: I. Clinical features. Ann Neurol 1986, 19:517–524.

    Article  PubMed  CAS  Google Scholar 

  4. Price RW, Navia BA, Cho ES: AIDS encephalopathy. Neurol Clin 1986, 4:285–301.

    PubMed  CAS  Google Scholar 

  5. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991, 41:778–785.

  6. Sacktor NC, Bacellar H, Hoover DR, et al.: Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 1996, 2:404–410.

    Article  PubMed  CAS  Google Scholar 

  7. Wilkie FL, Goodkin K, Eisdorfer C, et al.: Mild cognitive impairment and risk of mortality in HIV-1 infection. J Neuropsychiatry Clin Neurosci 1998, 10:125–132.

    PubMed  CAS  Google Scholar 

  8. Valcour VG, Shikuma CM, Watters MR, Sacktor NC: Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS 2004, 18(Suppl 1):S79–S86.

    PubMed  Google Scholar 

  9. Sacktor N, Lyles RH, Skolasky R, et al.: HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001, 56:257–260.

    PubMed  CAS  Google Scholar 

  10. Ferrando S, van Gorp W, McElhiney M, et al.: Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 1998, 12:F65–F70.

    Article  PubMed  CAS  Google Scholar 

  11. Starace F, Bartoli L, Aloisi MS, et al.: Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study. Acta Psychiatr Scand 2002, 106:20–26.

    Article  PubMed  CAS  Google Scholar 

  12. Ellis R, Langford D, Masliah E: HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 2007, 8:33–44.

    Article  PubMed  CAS  Google Scholar 

  13. Antinori A, Arendt G, Becker JT, et al.: Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789–1799.

    Article  PubMed  CAS  Google Scholar 

  14. Gonzalez RG, Cheng LL, Westmoreland SV, et al.: Early brain injury in the SIV-macaque model of AIDS. AIDS 2000, 14:2841–2849.

    Article  PubMed  CAS  Google Scholar 

  15. Gray F, Lescs MC, Keohane C, et al.: Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 1992, 51:177–185.

    PubMed  CAS  Google Scholar 

  16. Kaul M, Garden GA, Lipton SA: Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988–994.

    Article  PubMed  CAS  Google Scholar 

  17. Ricardo-Dukelow M, Kadiu I, Rozek W, et al.: HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol 2007, 185:37–46.

    Article  PubMed  CAS  Google Scholar 

  18. Gonzalez-Scarano F, Martin-Garcia J: The neuropathogenesis of AIDS. Nat Rev Immunol 2005, 5:69–81.

    Article  PubMed  CAS  Google Scholar 

  19. Price RW: The two faces of HIV infection of cerebrospinal fluid. Trends Microbiol 2000, 8:387–391.

    Article  PubMed  CAS  Google Scholar 

  20. Strain MC, Letendre S, Pillai SK, et al.: Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 2005, 79:1772–1788.

    Article  PubMed  CAS  Google Scholar 

  21. Achim CL, Wiley CA: inflammation in AIDS and the role of the macrophage in brain pathology. Curr Opin Neurol 1996, 9:221–225.

    Article  PubMed  CAS  Google Scholar 

  22. Adamson DC, Wildemann B, Sasaki M, et al.: Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917–1921.

    Article  PubMed  CAS  Google Scholar 

  23. Nottet HS, Gendelman HE: Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today 1995, 16:441–448.

    Article  PubMed  CAS  Google Scholar 

  24. Sharer LR: Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 1992, 51:3–11.

    Article  PubMed  CAS  Google Scholar 

  25. Masliah E, Heaton RK, Marcotte TD, et al.: Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997, 42:963–972.

    Article  PubMed  CAS  Google Scholar 

  26. Langford D, Marquie-Beck J, de Almeida S, et al.: Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J Neurovirol 2006, 12:100–107.

    Article  PubMed  CAS  Google Scholar 

  27. Ances BM, Ellis RJ: Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007, 27:86–92.

    Article  PubMed  Google Scholar 

  28. Castellon SA, Hinkin CH, Wood S, Yarema KT: Apathy, depression, and cognitive performance in HIV-1 infection. J Neuropsychiatry Clin Neurosci 1998, 10:320–329.

    PubMed  CAS  Google Scholar 

  29. Power C, Selnes OA, Grim JA, McArthur JC: HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:273–278.

    Article  PubMed  CAS  Google Scholar 

  30. Smith CA, van Gorp WG, Ryan ER, et al.: Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J Acquir Immune Defic Syndr 2003, 33:116–118.

    PubMed  Google Scholar 

  31. Wojna V, Nath A: Challenges to the diagnosis and management of HIV dementia. AIDS Read 2006, 16:615–616, 621–614, 626, 629–632.

    PubMed  Google Scholar 

  32. Clifford DB, Yang Y, Evans S: Neurologic consequences of hepatitis C and human immunodeficiency virus coinfection. J Neurovirol 2005, 11(Suppl 3):67–71.

    Article  PubMed  Google Scholar 

  33. Clifford DB, Evans S, Yang Y, et al.: Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med 2005, 143:714–721.

    PubMed  CAS  Google Scholar 

  34. Hestad K, McArthur JH, Dal Pan GJ, et al.: Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand 1993, 88:112–118.

    Article  PubMed  CAS  Google Scholar 

  35. Ernst T, Chang L, Arnold S: Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage 2003, 19:1686–1693.

    Article  PubMed  CAS  Google Scholar 

  36. Meyerhoff DJ, Bloomer C, Cardenas V, et al.: Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999, 52:995–1003.

    PubMed  CAS  Google Scholar 

  37. Ragin AB, Storey P, Cohen BA, et al.: Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol 2004, 25:195–200.

    PubMed  Google Scholar 

  38. Chang L, Tomasi D, Yakupov R, et al.: Adaptation of the attention network in human immunodeficiency virus brain injury. Ann Neurol 2004, 56:259–272.

    Article  PubMed  Google Scholar 

  39. Ances BM, Roc AC, Wang J, et al.: Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology 2006, 66:862–866.

    Article  PubMed  CAS  Google Scholar 

  40. Cysique LA, Brew BJ, Halman M, et al.: Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr 2005, 39:426–429.

    Article  PubMed  CAS  Google Scholar 

  41. Ellis RJ, Hsia K, Spector SA, et al.: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol 1997, 42:679–688.

    Article  PubMed  CAS  Google Scholar 

  42. Price RW, Epstein LG, Becker JT, et al.: Biomarkers of HIV-1 CNS infection and injury. Neurology 2007, 69:1781–1788.

    Article  PubMed  CAS  Google Scholar 

  43. Gisslen M, Hagberg L, Brew BJ, et al.: Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis 2007, 195:1774–1778.

    Article  PubMed  CAS  Google Scholar 

  44. Brew BJ, Pemberton L, Blennow K, et al.: CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 2005, 65:1490–1492.

    Article  PubMed  CAS  Google Scholar 

  45. Hinkin CH, Castellon SA, Durvasula RS, et al.: Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002, 59:1944–1950.

    PubMed  CAS  Google Scholar 

  46. Venkataramana A, Pardo CA, McArthur JC, et al.: Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 2006, 67:383–388.

    Article  PubMed  CAS  Google Scholar 

  47. Letendre S, Marquie-Beck J, Capparelli E, et al.: Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008, 65:65–70.

    Article  PubMed  Google Scholar 

  48. Ances BM, Roc AC, Korczykowski M, et al.: Combination anti-retroviral therapy modulates the blood oxygen level dependent amplitude in HIV+ patients. J Neurovirol 2008 (in press).

  49. Sacktor N, Schifitto G, McDermott MP, et al.: Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study. Neurology 2000, 54:233–235.

    PubMed  CAS  Google Scholar 

  50. Zink MC, Uhrlaub J, DeWitt J, et al.: Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005, 293:2003–2011.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Washington, 660 South Euclid Avenue, Box 8111, St. Louis, MO, 63130, USA

    David B. Clifford

Authors
  1. Beau M. Ances
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David B. Clifford
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David B. Clifford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ances, B.M., Clifford, D.B. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Curr Neurol Neurosci Rep 8, 455–461 (2008). https://doi.org/10.1007/s11910-008-0073-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-008-0073-3

Keywords

Search

Navigation